These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30512408)

  • 1. [Burkitt lymphoma, a diagnostic emergency].
    Bredin S; Vergé V; Ribrag V
    Rev Prat; 2016 Jan; 66(1):79-82. PubMed ID: 30512408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Burkitt lymphoma: advances in diagnosis and treatment.
    Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO
    Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Burkitt lymphoma in children and adults: Lessons from Africa.
    Magrath IT
    Curr Hematol Malig Rep; 2006 Dec; 1(4):230-40. PubMed ID: 20425318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
    Oosten LEM; Chamuleau MED; Thielen FW; de Wreede LC; Siemes C; Doorduijn JK; Smeekes OS; Kersten MJ; Hardi L; Baars JW; Demandt AMP; Stevens WBC; Nijland M; van Imhoff GW; Brouwer R; Uyl-de Groot CA; Kluin PM; de Jong D; Veelken H
    Ann Hematol; 2018 Feb; 97(2):255-266. PubMed ID: 29209924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Efficacy and Prognostic Factors of Newly Diagnosed Children[JP] with Burkitt Lymphoma Treated by High-Dose and Short-Course Modified LMB Regimen ± Rituximab].
    Wang BT; Dang HB; Wei YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):529-534. PubMed ID: 32319391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adults with Burkitt lymphoma.
    Gastwirt JP; Roschewski M
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):812-822. PubMed ID: 30843890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
    Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
    Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Burkitt Lymphoma in Adults.
    Casulo C; Friedberg J
    Curr Hematol Malig Rep; 2015 Sep; 10(3):266-71. PubMed ID: 26013028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
    Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
    Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
    Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkitt lymphoma in children: the Israeli experience.
    Eldar AH; Futerman B; Abrahami G; Attias D; Barak AB; Burstein Y; Dvir R; Gabriel H; Horovitz J; Kapelushnik J; Kaplinsky H; Miskin H; Sthoeger D; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Arush MB
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):428-36. PubMed ID: 19648792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
    Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
    AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study.
    Samochatova EV; Maschan AA; Shelikhova LN; Myakova NV; Belogurova MB; Khlebnikova OP; Shamardina AV; Ryskal OV; Roumiantseva JV; Konovalov DM; Dubrovina ME; Rumyantsev AG
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):395-401. PubMed ID: 23823112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.
    Kelly JL; Toothaker SR; Ciminello L; Hoelzer D; Holte H; LaCasce AS; Mead G; Thomas D; Van Imhoff GW; Kahl BS; Cheson BD; Magrath IT; Fisher RI; Friedberg JW
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):307-10. PubMed ID: 19717381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
    Miles RR; Arnold S; Cairo MS
    Br J Haematol; 2012 Mar; 156(6):730-43. PubMed ID: 22260323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
    Todeschini G; Bonifacio M; Tecchio C; Balter R; Carli G; Stefani PM; Adami F; Zamò A; Dei Tos AP; Marino F; Gherlinzoni F; Marradi P; Semenzato G; Pizzolo G
    Am J Hematol; 2012 Jan; 87(1):22-5. PubMed ID: 22086870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and prognostic analysis of 186 children with Burkitt's lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):605-610. PubMed ID: 30078243
    [No Abstract]   [Full Text] [Related]  

  • 19. [Burkitt's lymphoma--a case report].
    Obeid L; Schär B; Heitzmann F; Bargetzi M
    Praxis (Bern 1994); 1999 Sep; 88(36):1444-8. PubMed ID: 10500420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.
    Smyth L; Browne PV; Conneally E; Flynn C; Hayden P; Jeffers M; O'Brien D; Quinn F; Kelly J; Perera M; Crotty GM; Leahy M; Hennessy B; Jackson F; Ryan M; Vandenberghe E
    Ir J Med Sci; 2016 Nov; 185(4):773-777. PubMed ID: 25843016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.